Unstimulated polymorphonuclear neutrophils regulate proximal coronary arterial tone

International Journal of Cardiology

Volumn 55, Issue 1, 1996, Pages 15-27

  Abe, Yukihiko ^a   Saito, Tomiyoshi ^a   Kuroda, Satoshi ^a   Ishibashi, Toshiyuki ^a   Keitoku, Mitsumasa ^b   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Coronary arterial tone; Endothelium; Pig; Prostaglandin E2; Unstimulated polymorphonuclear neutrophils

Indexed keywords

ANTIBODY; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E2; RINGER SOLUTION; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY TONE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; MICROSCOPY; MUSCLE ISOMETRIC CONTRACTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE TONE; SWINE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0030570395     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02624-1     Document Type: Article

References (38)

1. [1] Gillespie MN, Kojima S, Kunitomo M, Jay M. Coronary and myocardial effects of activated neutrophils in perfused rabbit hearts. J Pharmacol Exp Ther 1986; 239: 836-840.
2. [2] Ohlstein EH, Nichols AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscles. Circ Res 1989; 65: 917-924.
3. [3] Sobey CC, Dusting GJ, Stewart AG, Woodman OL. Rabbit polymorphonuclear leukocytes cause endothelium-dependent contraction of rabbit aorta. J Vasc Med Biol 1990; 2: 107-115.
4. [4] Sessa WC, Mullane KM. Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro. Br J Pharmacol 1990; 99: 553-559.
5. [5] Nishida M, Kuzuya T, Hoshida S, Kim Y, Kitabatake A, Kamada T, Tada M. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 1990; 66: 253-258.
6. [6] Ma X-L, Tsao PS, Viehman GE, Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res 1991; 69: 95-106.
7. [7] Sobey CG, Dusting GJ, Stewart AG. Tumor necrosis factor a augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. J Cardiovasc Pharmacol 1992; 20: 813-819.
8. [8] Grossman HJ, Zambetis M. Leukocyte-induced endothelium-dependent vasodilatation and post-ischaemic vasospasm in the isolated rat superior mesenteric artery. Br J Exp Pathol 1989; 70: 515-523.
9. [9] Mehta JL, Lawson DL, Nichols WW, Mehta P. Modulation of vascular tone by neutrophils: dependence on endothelial integrity. Am J Physiol 1989; 257: H1315-1320.
10. [10] McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 1989; 261: 293-296.
11. [11] Rimele TJ, Sturm RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D. interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245: 102-111.
12. [12] Ishibashi T, Miller SL, Burstein SA. Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood 1987; 69: 1737-1741.
13. [13] Berliner JA, Territo M, Almada L, Carter A, Shatonsky E, Fogelman AM. Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis 1986; 6: 254-259.
14. 2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 1986; 334: 468-474.
15. 2 analogs and prostaglandins in isolated dog arteries. J Cardiovasc Pharmacol 1986; 8: 818-825.
16. 2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. Eur J Pharmacol 1989; 163: 253-261
17. [17] Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: Are there two relaxing mediators? Circ Res 1987; 61(suppl II): II-61-II-67.
18. [18] Beny JL, Brunet PC, Van der Bent V. Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effects. Experientia 1989; 45: 132-134.
19. [19] Piomelli D, Feinmark SJ, Cannon PJ. Leukotrien biosynthesis by canine and human coronary arteries. J Pharmacol Exp Ther 1987; 241: 763-770.
20. 4 release due to severe stenosis in the canine coronary artery stimulated by the calcium ionophore A23187. Biochem Pharmacol 1986; 35: 3593-3599.
21. 2 synthetase inhibitors. 2. syntheses and activities of tetrahydronaphthalene and indan derivatives. J Med Chem 1989; 32: 1326-1334.
22. [22] Sakuma K, Kawamoto S, Watanabe K, Ashida S. FMLP-induced coronary flow reduction in isolated hearts of hypercholesterolemic rabbits and its inhibition by DP1904. Eur J Pharmacol 1990; 183: 791.
23. [23] Douglas SA, Hiley CR. Endothelium-dependent vascular activities of endothelium-like peptides in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol 1990; 101: 81-88.
24. [24] Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. A human leukocyte differentiation antigen family with distinct α-subunits and a common β-subunit: The lymphocyte function-associated antigen(LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150, 95 molecule. J Exp Med 1983; 158: 1785-1803.
25. [25] Lunney JK. Characterization of swine leukocyte differentiation antigens. Immunol Today 1993; 14: 147-148.
26. [26] Babior BM, Kipnes RS, Cunutte JT. The production by leukocytes of superoxide, a potential bacterialicidal agent. J Clin Invest 1973; 52: 741-744.
27. 1 in the rabbit hindquarters vascular bed. Prostaglandins Med 1980; 4: 1-11.
28. [28] Dusting GJ, Moncada S, Vane JR. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Eur J Pharmacol 1978; 49: 65-72.
29. [29] Kulkarni PS, Roberts R, Needleman P. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins 1976; 12: 337-353.
30. [30] Lopez JAG, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD. Vascular responses to leukocyte products in atherosclerotic primates. Circ Res 1989; 65: 1078-1086.
31. [31] Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
32. [32] Fantone JA, Ward PA. Role of oxygen derived free radicals and metabolites in leukocyte-depedent inflammatory reactions. Am J Pathol 1982; 107: 397-418.
33. [33] Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 1986; 26: 201-224.
34. [34] Harlan JM. Leukocyte-endothelial interactions. Blood 1985; 65: 513-525.
35. [35] Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991; 84: 1758-1772.
36. [36] Gerrity RG, Gass JA, Soby L. Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis 1985; 5: 55-66.
37. [37] Mazzone T, Jensen M, Chait A. Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci USA 1983; 80: 5094-5097.
38. [38] Jauchem JR, Lopez M, Sprague EA, Schwartz CJ. Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Path 1982; 37: 166-170.